Ten-year conditional recurrence risks and overall and relative survival for breast cancer patients in the Netherlands: Taking account of event-free years-Reference-Cited by-同舟云学术

Ten-year conditional recurrence risks and overall and relative survival for breast cancer patients in the Netherlands: Taking account of event-free years

Published:2018-10 Issue: Volume:102 Page:82-94
ISSN:0959-8049
Container-title:European Journal of Cancer
language:en
Short-container-title:European Journal of Cancer

Author:

van Maaren Marissa C.,Strobbe Luc J.A.,Smidt Marjolein L.,Moossdorff Martine,Poortmans Philip M.P.,Siesling Sabine^ORCID

Publisher

Elsevier BV

Subject

Cancer Research,Oncology

Reference36 articles.

1. American Society of Clinical Oncology/College of American Pathologists guideline recommendations for human epidermal growth factor receptor 2 testing in breast cancer;Wolff;J Clin Oncol,2007

2. Breast cancer diagnosis and death in The Netherlands: a changing burden;van der Waal;Eur J Public Health,2015

3. When do I know I am cured? Using conditional estimates to provide better information about cancer survival prospects;Baade;Med J Aust,2011

4. Conditional survival of cancer patients: an Australian perspective;Yu;BMC Cancer,2012

5. Prognostic model for advanced breast carcinoma with luminal subtype and impact of hormonal maintenance: implications for post-progression and conditional survival;Carbognin;Breast,2016

Cited by 17 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Personalized surveillance and aftercare for non-metastasized breast cancer: the NABOR study protocol of a multiple interrupted time series design;BMC Cancer;2023-11-14

2. Breast cancer mortality in 500 000 women with early invasive breast cancer diagnosed in England, 1993-2015: population based observational cohort study;BMJ;2023-06-13

3. Long term risk of distant metastasis in women with non‐metastatic breast cancer and survival after metastasis detection: a population‐based linked health records study;Medical Journal of Australia;2022-08-20

4. Added value of repeat sentinel lymph node biopsy in FDG-PET/CT node-negative patients with ipsilateral breast cancer recurrence;Breast Cancer Research and Treatment;2022-06-21

5. ANLN and UBE2T are prognostic biomarkers associated with immune regulation in breast cancer: a bioinformatics analysis;Cancer Cell International;2022-05-16